Anatomy-led
No gauge guide
Clinician-only
Women’s Health Clinic FAQ
What specific micro-cannula gauges (27G vs. 30G) minimise shear stress and prevent premature platelet activation during injection?
Delivery and anatomy questions need a clear boundary: patient education should not become an injection manual.
Direct answer
Specific cannula gauge choices should not be given as public O-Shot instructions. The benchmark should explain shear stress and platelet activation as clinician-managed considerations within anatomy, tissue comfort and safety.
The answer should connect PRP preparation science with symptoms, tissue state, medicines, governance and evidence limits before suggesting whether treatment is suitable.
Educational only. Use this as general education before discussing your own symptoms with a clinician. Results vary. Not a cure.
O-Shot suitability review
At a glance
These points frame the technical question before considering treatment suitability.
At a glance
Clinical summary
Tools
Cannula gauge, shear stress and platelet activation are clinician-managed considerations.
Volume
PRP volume should not be calculated from a public formula.
Anatomy
Clitoral phimosis and anterior-wall thinning involve different tissues and risks.
Assessment
Placement, delivery and deferral decisions depend on examination and consent.
Important safety note
Seek medical advice promptly for heavy or persistent bleeding, fever, offensive discharge, ulcers, severe pelvic or vulval pain, urinary retention, worsening swelling, suspected infection or symptoms that feel unusual after treatment.
Sample quality
Suitability
Evidence
Review
Detailed answer
Detailed answer
Delivery details such as micro-cannula gauge, shear stress and PRP volume belong in trained clinical decision-making.
Clinical context
A smaller device or different volume is not automatically safer or more effective for every tissue problem.
Processing
Safety
Evidence
What matters first
Delivery details such as micro-cannula gauge, shear stress and PRP volume belong in trained clinical decision-making.
Biological logic
A smaller device or different volume is not automatically safer or more effective for every tissue problem.
Evidence boundary
Focal clitoral phimosis, vestibular tissue concerns and generalised anterior-wall thinning need different assessment pathways.
Safety boundary
The safest page explains anatomy, comfort and evidence limits while refusing public gauge, volume or placement instructions.
What this means in practice
A useful answer explains the PRP variable without becoming a public lab protocol or injection guide.
Sample handling, medicine review, device protocols, activity advice and treatment details should be confirmed by the treating clinician.
Patient safety
Why this matters
Technical PRP questions matter because sample preparation, tissue response and patient symptoms are connected, but not interchangeable.
It avoids false precision
A lab variable can matter without producing a simple public target or predictable result.
It protects sensitive tissue
Genital tissue can be affected by menopause, inflammation, infection, scarring, medicines and pelvic-floor pain.
It keeps governance visible
PRP preparation should follow trained protocols, equipment instructions and infection-control standards.
It supports consent
Patients should understand uncertainty, discomfort, bleeding, bruising and aftercare before choosing treatment.
A careful treatment conversation
The right question is not only whether PRP biology is plausible, but whether the treatment fits the patient's symptoms and medical context.
That is why consultation, review and clear safety advice are central to responsible intimate PRP care.
Considerations
What to consider
Consider the main symptom, tissue health, menopause status, medicines, infection symptoms, bleeding history, smoking or vaping, sample-processing governance and treatment goals.
Consultation priorities
Assessment identifies whether the concern is clitoral, vestibular, anterior-wall, pain-related, GSM-related, urinary or sexual-function related.
Sample
Tissue
Follow-up
Assessment
Assessment identifies whether the concern is clitoral, vestibular, anterior-wall, pain-related, GSM-related, urinary or sexual-function related.
Safety review
The clinician reviews skin disease, scarring, tissue thinning, pelvic-floor pain, infection, bleeding risk and medicines.
Treatment fit
If PRP is suitable, delivery choices remain clinician-led and should be explained through consent rather than protocol disclosure.
Review
Review checks pain, bruising, bleeding, swelling, urinary symptoms and whether the target symptom has changed.
Practical expectations
Response can be partial, delayed or absent, and published intimate PRP protocols are not uniform.
Prices, exact processing details, injection approach, treatment timing and aftercare should be confirmed with the clinic before booking.
Common concerns and myths
Common misconceptions
These myths can make PRP preparation sound more controllable than it really is.
Myth: smaller cannulas are always better
Reality: tool choice depends on tissue, comfort, flow and clinician judgement.
Myth: PRP volume can be adjusted from a formula
Reality: volume decisions require examination and procedural expertise.
Myth: clitoral phimosis and anterior-wall thinning are the same
Reality: they involve different anatomy and different clinical questions.
Evidence and context
Mechanism helps explain why PRP is considered, but it does not replace diagnosis, clinical evidence or suitability checks.
Different outcomes
Sample quality, platelet signalling, tissue comfort, lubrication, orgasm and pain are different questions and should not be blurred together.
Safety checklist
Safety checklist
Use these checks before assuming intimate PRP is suitable.
Is the symptom clear?
Clarify whether the concern is orgasm, arousal, lubrication, pain, sensitivity, urinary leakage or tissue comfort.
Has sample context been reviewed?
Medicines, bleeding history, infection risk, tissue condition and clinic processing standards can affect suitability.
Are red flags absent?
Pause and seek clinical review for new bleeding, fever, offensive discharge, ulcers, severe pain, urinary retention, spreading swelling or any concern about infection.
Is uncertainty documented?
Consent should explain limited evidence, variable response and possible discomfort, bruising or bleeding.
Reassuring signs
Proceeding is more reasonable when symptoms are clearly assessed, red flags are absent and expectations are realistic.
No red flags
Review plan
Reasons to pause
Pause for new bleeding, infection symptoms, ulcers, severe pain, urinary retention, spreading swelling, active vulval disease or uncertainty about medicine safety.
Infection
Severe pain
When to escalate
When to seek medical help
Some symptoms around intimate PRP treatment need prompt assessment.
Use NHS 111 online
Bleeding
Heavy bleeding, persistent bleeding or bleeding after sex should be assessed by a clinician.
Infection symptoms
Fever, offensive discharge, worsening burning, ulcers or pelvic pain may need swabs, urine testing or review.
Unexpected reaction
Worsening swelling, severe soreness, feverish symptoms or tissue colour change should be reviewed.
Emergency symptoms
Call 999 in a life-threatening emergency, including collapse, chest pain, breathing difficulty or sudden neurological symptoms.
Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.
More clinical detail
Why shear stress is mentioned
Platelets can be sensitive to handling and mechanical forces. This is a procedural consideration, not a reason for patients to request a gauge.Why anatomy changes delivery decisions
Clitoral phimosis, vestibular symptoms and anterior-wall thinning are not interchangeable. Each needs assessment before any injection is considered.Regulatory resources
Authoritative resources
These resources support evidence-aware, assessment-led discussion of intimate PRP and relevant safety issues.
O-Shot official questions
Competitor anchor for injection areas and numbing claims that require more precise boundaries.
O Shot and G Shot London competitor page
UK competitor page useful for procedure, downtime and expectation gaps.
Skin Excellence O-Shot competitor page
UK competitor page showing common rejuvenation and sexual-function messaging.
Next step
Book an intimate health consultation
A consultation can clarify whether symptoms fit GSM, sexual-function concerns, pelvic-floor pain, urinary symptoms or another cause, and whether PRP is suitable.
▶ View Research Sources (12 Sources)
These 12 source names are selected from 250 curated sources. Additional reviewed material included peer-reviewed clinical papers, evidence reviews, clinical trial records; duplicate and low-relevance records were removed before display.
Educational only. This information is for education only and is not a substitute for professional medical advice, diagnosis or treatment. Results vary. Not a cure.
